Stay up-to-date with the latest Forex news

The Forex world is constantly evolving and during its weekly trading hours there is a wealth of news a trader must keep on top of if they want to make the most money possible. Indeed, because the market can be affected by a number of dynamics, it is essential they know exactly what’s happening at all times in order to avoid any unprofitable deals.

For example, let’s assume the US Dollar is trading well against the Great British Pound during the first half of the week. This would be a good time to invest some money and reap the benefits of a positive market condition. However, by Wednesday a series of negative news stories emerge from the UK and affect the country’s economic performance. These dynamics then adversely affects how well the two currencies are trading. At this point it’s important to know what’s just happened because it will influence whether or not someone should cease trading this currency pair for a while or continue.

Knowing the value of each currency based on various internal and external factors is crucial and the reason why’s Forex news centre is a vital resource. Drawing on a number of resources, our information section provides the latest information and data from which users can refine their trading activity.

Beyond shifts in the currency market itself,’s new section has been designed to give traders an insight into the best offers and promotions. By monitoring each of our 200+ Forex brokers we’re able to quickly tell users about the latest updates and bonuses.

By compiling all this current data into one portal we believe investors will be able to make even more money in the Forex market. Indeed, thanks to our dedicated team of analysts and experts, users can find out the latest market developments as well as the best deals in the industry. Putting all this together should help everyone gain a better understanding of the market, which in turn should give them the ability to make even more money.


Tesla shares rise as Musk says Cybertruck orders hit 200,000
Nov. 25, 2019, 2:22 p.m.

Tesla opened preorders immediately, however, and allowed potential buyers to book the truck by depositing a fully refundable $100, compared to the $1,000 Tesla charged for boo ..

UPDATE 2-CymaBay Therapeutics scraps two studies of liver drug; shares plunge
Nov. 25, 2019, 2:14 p.m.

CymaBay Therapeutics Inc said on Monday it was scrapping two mid-stage trials of its liver disease drug, after biopsies found a type of liver damage in some patients, sending ..

Investors Who Bought Zogenix (NASDAQ:ZGNX) Shares Five Years Ago Are Now Up 411%
Nov. 25, 2019, 2:13 p.m.

We think all investors should try to buy and hold high quality multi-year winners. While not every stock performs... ..

Is Northern Graphite (CVE:NGC) In A Good Position To Deliver On Growth Plans?
Nov. 25, 2019, 2:06 p.m.

We can readily understand why investors are attracted to unprofitable companies. For example, although... ..

Hedge Funds Are Optimistic About Merck & Co., Inc. (MRK)
Nov. 25, 2019, 2:01 p.m.

We can judge whether Merck & Co., Inc. (NYSE:MRK) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. ..

Gene Editing Might Alter Our DNA. It Might Destroy Our Humanity, Too.
Nov. 25, 2019, 2 p.m.

Biologists recently revealed a new form of the gene-editing tool known as Crispr that allows researchers to make precise changes to almost any element of DNA, permanently alte ..

Stifel Upgrades Wendy's, Bullish On Breakfast And Digital Prospects
Nov. 25, 2019, 1:56 p.m.

Stifel analysts met with Wendys Co (NASDAQ: WEN ) management team and left hungry for the stock. The Analyst Stifel analyst Chris O'Cull upgraded Wendy's from Hold to Buy with ..

UPDATE 1-Apple supplier Salcomp to invest $279 mln in new Indian plant
Nov. 25, 2019, 1:51 p.m.

Finland's Salcomp, a supplier to U.S. tech group Apple, is to invest 20 billion rupees ($278.67 million) in India to make mobile chargers and other smartphone components from ..

UPDATE 1-FDA declines to approve Adamis Pharma's Zimhi to treat opioid overdose
Nov. 25, 2019, 1:44 p.m.

Adamis Pharmaceuticals Corp said on Monday the U.S. Food and Drug Administration declined to approve its opioid overdose treatment, raising questions around its chemistry, man ..

This Biotech Deal Is a $10 Billion Leap of Faith
Nov. 25, 2019, 1:41 p.m.

(Bloomberg Opinion) -- Novartis AG’s latest biotech bolt-on requires a big leap of faith. The Swiss drugmaker’s $9.7 billion deal to buy Medicines Co. pays the U.S. cardiovasc ..

Social Pulse

FxBrokerSearch Newsletter

Top Brokers

Risk Disclosure: will not be held liable for any financial loss or damage caused by users acting upon any information contained within this website, not limited to and including: all numerical data, quotes, charts and buy/sell signals. Moreover, please be advised that Forex trading is one of the most volatile investment forms in the world and all trades should be placed with full consideration of the risks and costs. does not support nor encourage the execution of any investments. Trading with a margin is high risk endeavour and not suitable for everyone, therefore, each investor should carefully consider all relevant trading conditions, such as experience, risk and cost, before taking part in any type of trading, including Forex.

While every effort has been made to ensure all our data is as accurate as possible, cannot be held responsible for any prices that are not in line with real-time data. Indeed, the currency exchange market is constantly changing and all CFDs (stocks, indexes, futures) and Forex prices are set by market makers.

This means advertised prices may not be accurate and could differ from the actual market conditions. For this reason it is not appropriate to rely on any data presented by for the purposes of trading.

Based on these conditions, will not be held responsible for any losses incurred through trades conducted in light of data presented on this site.